Core Laboratories Cuts Q1 Guidance to Account for Middle East Conflict

MT Newswires Live03-24

Core Laboratories (CLB) said late Monday it now expects Q1 adjusted earnings of $0.05 to $0.07, from $0.11 to $0.15 earlier.

Three analysts polled by FactSet expect $0.13.

The company now expects Q1 revenue of $119 million to $123 million, from $124 million to $130 million earlier.

Three analysts surveyed by FactSet expected $127.5 million.

The company said it revised down its Q1 guidance to account for the impact from the Middle East conflict on project timelines, travel, and supply chains.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment